William Pickering
Stock Analyst at Bernstein
(1.15)
# 3,499
Out of 4,839 analysts
23
Total ratings
40%
Success rate
-8.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $289.00 | +7.27% | 2 | Jan 7, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $1,110 → $1,070 | $596.85 | +79.27% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $15.39 | +55.95% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $15.43 | +327.74% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $58.01 | +55.15% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $33.26 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $434.03 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $9.46 | +470.82% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $17.24 | +114.62% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $1.09 | +450.46% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $37.53 | +17.24% | 1 | Mar 21, 2023 |
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $289.00
Upside: +7.27%
Regeneron Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $1,110 → $1,070
Current: $596.85
Upside: +79.27%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $15.39
Upside: +55.95%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $15.43
Upside: +327.74%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $58.01
Upside: +55.15%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $33.26
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $434.03
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $9.46
Upside: +470.82%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $17.24
Upside: +114.62%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.09
Upside: +450.46%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $37.53
Upside: +17.24%